Clover Health Investments, Corp. (CLOV)

NASDAQ: CLOV · USD

$4.78

+0.15 (+3.2%)· Recorded snapshot

Market cap	2.5B
Revenue (ttm)	2.5B
Net income (ttm)	-18.4M
EPS (ttm)	-$0.04
Shares out	531.2M
P/E (forward)	65.8x
Volume	2,496,271
Beta	2.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.5B
Net income (ttm): -18.4M
EPS (ttm): -$0.04
P/E (forward): 65.8x
Market cap: 2.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E65.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-5.1

P25 n/aP50 n/aP75 n/a

ROIC-3.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CLOV indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001801170
Company name	Clover Health Investments, Corp.
Country	United States
Country code	US
CUSIP number	18914F103
Earnings date	2026-11-04
Earnings time	amc
Employees	724
Employees change	154
Employees growth	27.02%
Enterprise value	$2.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Healthcare Plans
Is primary listing	Yes
Is SPAC	No
ISIN number	US18914F1030
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.5B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$4.78
Price currency	USD
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-28
Symbol	CLOV
U.S. state	Delaware
Website	https://www.cloverhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	45.09x
Earnings yield	-0.86%
EV/FCF	31.39x
EV/Sales	0.94x
FCF / EV yield	3.19%
FCF yield	2.94%
Forward EV/Sales	0.72x
Forward P/E	65.84x
Forward P/S	0.78x
Industry forward P/E	15.03x
Industry P/E	21.44x
P/(FCF - SBC) ratio	1,382.34x
P/(OCF - SBC) ratio	543.25x
P/B ratio	6.51x
P/FCF ratio	34.07x
P/OCF ratio	32.82x
P/S ratio	1.02x
Price / tangible book value	6.77x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-0.74%
EBITDA margin	-0.73%
FCF margin	3%
Gross margin	18.54%
Operating margin	-0.74%
Pretax margin	-0.74%
Profit margin	-0.74%
Profit per employee	$-25,362
Profitable quarters	2
Revenue per employee	$3.4M
ROA	-1.77%
ROA (5Y)	-23.26%
ROCE	-4.62%
ROE	-5.1%
ROE (5Y)	-95.53%
ROIC	-3.19%
SBC / revenue	2.92%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	0%
EPS growth quarters	1
EPS growth years	0
FCF growth (Q)	406.43%
FCF growth (QoQ)	-77.11%
Net income growth (QoQ)	2.44%
Net income growth quarters	2
Net income growth years	0
OCF growth (Q)	365.75%
OCF growth (QoQ)	-76.66%
Revenue growth	53.98%
Revenue growth (Q)	55.6%
Revenue growth (QoQ)	-0.8%
Revenue growth 3Y	0.47%
Revenue growth 5Y	21.85%
Revenue growth quarters	11
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.8M
EBIT	$-18.4M
EBITDA	$-18M
EPS	$-0.04
FCF per share	$0.14
Financing cash flow	$-21.3M
Free cash flow	$74.2M
Free cash flow minus SBC	$1.8M
Gross profit	$459.1M
Investing cash flow	$-45.5M
Net cash flow	$10.2M
Net income	$-18.4M
Operating cash flow minus SBC	$4.7M
Operating income	$-18.4M
Revenue	$2.5B
Stock-based compensation	$72.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.71
Debt / equity	0
Net cash (debt)	$198.8M
Net cash / market cap	7.86%
Net cash growth	5.4%
Net debt / equity	-0.53
Net debt / FCF	-2.68
Piotroski F-Score	3
Property, plant and equipment	$7.2M
Shareholders' equity	$376.3M
Tangible book value	$373.3M
Tangible book value per share	$0.71
Total assets	$720.3M
Total cash	$243.1M
Total debt	$0
Total liabilities	$344.1M
WACC	17.8%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	3.82
Current ratio	1.5
Net working capital	$-36.7M
Quick ratio	1.38
Working capital	$162.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.75%
Dividend yield	0%
Shareholder yield	-3.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$3.98
1D price change	3.24%
1M price change	6.01%
1M total return	6.01%
1W price change	-0.83%
1W total return	-0.83%
1Y price change	24.93%
1Y return CAGR	24.95%
1Y total return	24.93%
20-day SMA	$4.63
200-day SMA	$3.52
3M price change	11.48%
3M total return	11.48%
3Y price change	421.87%
3Y return CAGR	73.43%
3Y total return	421.87%
50-day SMA	$4.49
50-day SMA vs 200-day SMA	50over200
52-week high	$5.59
52-week high date	2026-06-29
52-week low	$1.58
52-week low date	2026-04-01
5Y price change	-34.53%
5Y return CAGR	-8.12%
5Y total return	-34.53%
6M price change	88.89%
6M total return	88.89%
All-time high	$28.85
All-time high date	2021-06-09
All-time low	$0.61
All-time low date	2024-04-22
Average true range (ATR)	$0.22
Average volume	4.1M
Beta (1Y)	2.98
Beta (2Y)	1.24
Beta (5Y)	2.46
Change from 52-week high	-14.49%
Change from 52-week low	202.53%
Change from all-time high	-83.5%
Change from all-time low	685.48%
Change from open	1.59%
Day's gap	1.62%
Dollar volume	$11.9M
High price	$4.85
Low price	$4.71
Monthly RSI	60.81
Open price	$4.71
Position in 52-week range	51.72%
Premarket change	1.08%
Premarket close	$4.63
Premarket price	$4.68
Premarket volume	26.7K
Previous close	$4.63
Price vs 150-day SMA	19.57%
Price vs 20-day SMA	2.74%
Price vs 200-day SMA	35.11%
Price vs 50-day SMA	5.99%
Relative volume	0.61
RSI	55.8
Sharpe ratio	0.6
Sharpe ratio (3Y)	1.06
Sharpe ratio (5Y)	0.19
Sortino ratio	1.07
Sortino ratio (3Y)	1.85
Sortino ratio (5Y)	0.37
Volume	2.5M
Weekly RSI	59.26
YTD price change	102.55%
YTD total return	102.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	412.7M
Float percentage	77.7%
Shares change (QoQ)	4.46%
Shares change (YoY)	3.75%
Shares held by insiders	21.64%
Shares held by institutions	28.38%
Shares outstanding	531.2M
Short % of float	6.29%
Short % of shares	4.89%
Short ratio	5.6 days

Deeper analysis on CLOV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CLOV report

Is a complete CLOV research report available?

No complete published report is available for Clover Health Investments, Corp. (CLOV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Clover Health Investments, Corp. (CLOV)

Price

Financial snapshot

Fair-value bridge

Latest news · CLOV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLOV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CLOV

Frequently asked questions